DOI:
10.1055/s-00000045
Der Nuklearmediziner
LinksClose Window
References
Strosberg J, El-Haddad G, Wolin E. et al.
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.
The New England journal of medicine 2017;
376: 125-135
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.